Tuberculosis and associated risk factors among children and adolescent population in Serbia: 12 year's retrospective study.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 03 12 2020
accepted: 09 02 2021
entrez: 9 7 2021
pubmed: 10 7 2021
medline: 6 1 2022
Statut: epublish

Résumé

Recognition and epidemiological control of childhood and adolescent tuberculosis (TB) is essential to achieve effective control of TB in general as it presents high risk for transmission in the community. The aim of the study is to provide a descriptive and analytic overview of the trends in childhood and adolescent TB notifications and treatment outcomes and to identify factors associated with treatment success in a twelve-year period in Serbia. We performed a retrospective trend analysis and analysis of treatment outcomes of 596 child and adolescent TB cases notified in Serbia in the period 2005-2016 from all health facilities, as well as logistic regression analysis to identify predictors of treatment success. Factors independently associated with treatment success were: new TB (OR=2.60; 95% CI: 1.45-3.74), male sex (OR=2.55; 95% CI: 2.09-3.00), pulmonary TB (OR=3.34; 95% CI: 2.34-4.34), comorbidities (OR=2.58; 95% CI: 2.24-2.91), age below 5 years (OR=0.37; 95% CI: 0.32-0.43), and social vulnerability (OR=0.40; 95% CI: 0.34-0.46). In order to improve TB treatment outcomes among children and adolescent population in Serbia, it is important to focus on female, age group 5-18, EPTB, retreatment cases and socially vulnerable groups.

Identifiants

pubmed: 34242192
doi: 10.3855/jidc.14451
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-825

Informations de copyright

Copyright (c) 2021 Maja B Stosic, Lidija Sagic, Danijela Simic, Verica Jovanovic, Violeta Rakic, Tatjana Adzic Vukicevic.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Maja B Stosic (MB)

Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia. maja_stosic@batut.org.rs.

Lidija Sagic (L)

Municipality Institute for Lung Diseases and Tuberculosis, Belgrade, Serbia.

Danijela Simic (D)

Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia.

Verica Jovanovic (V)

Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia.

Violeta Rakic (V)

Institute of Public Health of Serbia "Dr Milan Jovanovic Batut", Belgrade, Serbia.

Tatjana Adzic Vukicevic (T)

University Clinic for Pulmonology, Clinical Center of Serbia, Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH